Monday

cleanse your liver

(NaturalNews) If you experience major, persisting health problems, either physical or emotional, your liver may be congested with toxic compounds that are trapped within clumps of hardened bile (intrahepatic stones. Almost all health conditions, beauty problems and premature aging are closely linked with declined liver performance which most often is elusive to blood tests. Congestion in the bile ducts of the liver undermines the body's effort to make proper use of the food you eat. This, in turn, may lead to numerous physical ailments and accentuated expressions of discomfort, including fear, anger, impatience, greed, depression, dis-ease and cynicism. Cleansing the liver of existing obstructions and impurities can help restore balance, vitality and happiness in every facet of your life.

When the Body Complains…

Unlike the stomach, for example, the liver never tells you directly when it is upset or needs special attention. It tells you indirectly, though, when it starts to perform poorly. The following conditions are related to poor liver functions: skin irritation, weak eyesight, unhealthy bowel movements, irregular menstrual cycles, recurring headaches, unexplainable weight gain, loss of energy, sudden aging, elevated cholesterol levels, most allergies, constricted blood vessels, bloated abdomen, fluid retention, gastrointestinal trouble, breathing difficulties, poor memory and concentration, pain in the joints or elsewhere in the body, brittle bones and any other major illness such as heart disease, cancer, MS, diabetes or Alzheimer's disease.

The liver is responsible for processing, converting, distributing and maintaining the body's fuel supply which consists of nutrients and energy. Impeding these vital functions not only affects the body's performance as a whole, but also the health of every single cell. The liver cannot perform any of these functions properly if its bile ducts are clogged with deposits of hardened bile or "gallstones" (made of gall or bile).

Gallstones are caused by a number of factors, including the modern fast pace of living, stress, imbalanced diets, disruptive lifestyle, use of medical drugs, stimulants and alcohol, and ingestion of chemical poisons, such as food additives and artificial sweeteners. Bile duct congestion results in major impairment of digestive functions, thereby restricting the nutrient supply to the trillions of cells in the body. This makes gallstones in the liver to be a major cause of physical and emotional illness.

The Amazing Liver and Gallbladder Flush

The liver flush mentioned in this context is a straightforward, safe and painless do-it-yourself procedure using apple juice (or malic acid), olive oil, citrus juice and Epsom salts to dispel gallstones from both the liver and the gallbladder. The actual liver flush takes place within a period of less than fourteen hours and can be taken conveniently over a weekend at home.. Although the liver flush is very easy to do, it is important to understand the process and follow all of the directions precisely.

Since introducing the liver and gallbladder flush to thousands of patients in the 1990s, I have received countless testimonies expressing total amazement about the fast and profound healing effects it produces. They encouraged me to write a book on the subject. The 200-page book, The Amazing Liver and Gallbladder Flush, includes the exact procedure and necessary background information for conducting this simple, yet most profound cleanse. Today, the liver and gallbladder flush has helped restore the health of hundreds of thousands of people in all parts of the world.

Gallstones in the Liver—The Most Common Cause of Illness

An estimated 20 percent of the world's population will develop gallstones in their gallbladder at some stage in their lives; many of them will opt for surgical removal of this important organ. This statistical figure does not account, though, for the many more people who will develop gallstones (or already have them) in their liver. During some thirty years of practicing natural medicine and dealing with thousands of people suffering from all types of chronic diseases, I can attest to the fact that each one of them, without exception, has had considerable quantities of gallstones in his or her liver. Surprisingly, only relatively few of them reported to have had a history of gallstones in their gallbladder.

Gallstones in the liver may be the main impediment to acquiring and maintaining good health, youthfulness, and vitality. Gallstones in the liver may, indeed, be one of the major reasons people become ill and have difficulty recuperating from illness.

Medicine's Most Unfortunate Oversight

Many people believe that gallstones can be found only in the gallbladder. This is a commonly made yet false assumption. Most gallstones are actually formed in the liver, and comparatively few occur in the gallbladder. You can easily verify this assessment by giving yourself a liver flush. It matters little whether you are a layperson, a medical doctor, a scientist, or someone whose gallbladder was removed and, therefore, is believed to be stone free. The results of the liver flush speak for themselves. No amount of scientific proof or medical explanation can make such a cleanse any more valuable than it already is. Once you see hundreds of green, beige-colored, brown, or black gallstones floating in the toilet bowl during your first liver flush, you will intuitively know that you are on to something extremely important in your life.

I am repeatedly asked the intriguing question—why is there only little or no reference in mainstream medicine to the occurrence of gallstones in the liver? Standard clinical tests almost never reveal the occurrence of gallstones in the liver. In fact, most doctors don't even know they grow there. Only some of the most advanced research universities, such as the prestigious Johns Hopkins University, describe and illustrate these liver stones in their literature or on their web sites. They refer to them as "intrahepatic gallstones." The failure to recognize and accept the incidence of gallstone formation in the liver as an extremely common phenomenon may very well be the most unfortunate oversight that has ever been made in the field of medicine, both orthodox and holistic.

Relying so heavily on blood tests for diagnostic purposes, as conventional medicine does, may actually be a great disadvantage with regard to assessing liver health. Most people who have a physical complaint of one kind or another may show to have perfectly normal liver enzyme levels in the blood, despite suffering from liver congestion. Liver congestion is among the leading health problems, yet conventional medicine rarely refers to it, nor do doctors have a reliable way to detect and diagnose such a condition. Liver enzyme levels in the blood become elevated only when there is advanced liver cell destruction, as is the case, for example, in hepatitis or liver inflammation. Liver cells contain large amounts of enzymes. Once a certain number of liver cells are ruptured, their enzymes will start showing up in the blood. When detected through a blood test, this increased count of liver enzymes indicates abnormal liver functions. In such an event, however, the damage has already occurred. It takes many years of chronic liver congestion before liver damage becomes apparent.

Unfortunately, unless there is a specific liver disease, this vital organ is rarely considered a "culprit" for other diseases. The majority of gallstones in the liver consist of the same "harmless" constituents as are found in liquid bile, with cholesterol being the main ingredient. A number of stones consist of fatty acids and other organic material that has ended up in the bile ducts. The fact that the majority of these stones are just congealed clumps of bile or organic matter makes them practically "invisible" to x-rays, ultrasonic technologies, and Computer Tomography (CT).

The situation is different with regard to the gallbladder, where up to about 20 percent of all stones can be made-up entirely of minerals, predominantly, calcium salts and bile pigments. Whereas diagnostic tests can easily detect these hardened, relatively large stones in the gallbladder, they tend to miss the softer, non-calcified stones in the liver. Only when excessive amounts of cholesterol-based stones (85-95% cholesterol) or other clumps of fat block the bile ducts of the liver, may an ultrasound test reveal what is generally referred to as "fatty liver." In such a case, the ultrasound pictures reveal a liver that is almost completely white (instead of black). A fatty liver can gather up to 20,000 stones before it succumbs to suffocation and ceases to function.

If you had a fatty liver and went to the doctor, he would tell you that you had excessive fatty tissue in your liver. It is less likely, though, that he would tell you that you had intrahepatic gallstones (stones obstructing the liver's bile ducts). As mentioned before, most of the smaller stones in the liver are not detectable through ultrasound or Computer axial Tomography (CT). Nevertheless, careful analysis of diagnostic images by specialists would show whether some of the smaller bile ducts in the liver were dilated because of obstruction. A dilation of bile ducts caused by larger and denser stones or by clusters of stones may be detected more readily through Magnetic Resonance Imaging (MRI). However, unless there is an indication of major liver trouble, doctors rarely check for such intrahepatic stones. Unfortunately, although the liver is one of the most important organs in the body, its disorders are also under-diagnosed all too often.

Even if the early stages of a fatty liver or gallstone formation in the bile ducts were easily recognized and diagnosed, today's medical facilities offer no treatments to relieve this vital organ of the heavy burden it has to carry.

On the other hand, a qualified iridologist, an Ayurvedic physician or a natural health practitioner who knows the signs and indications of gallstones in the liver and gallbladder, can easily determine the extent of gallstone formation in these organs. [Such indicators are listed in the book The Amazing Liver and Gallbladder Flush,www.ener-chi.com.]Most people in the civilized world have gallstones. But even in alternative or holistic medicine, there is rarely mention of an effective therapy that can actually remove gallstones safely and without pain. Gallstones are a direct product of an unhealthy diet and lifestyle. If gallstones are still present in the liver even after all other disease-causing factors are eliminated, they pose a considerable health risk and may lead to illness and premature aging. By removing these stones, the body as a whole is able to resume its normal, healthy activities.

Reaping the Benefits

People with chronic illnesses often have several thousand gallstones congesting the bile ducts of the liver. Some stones may have also grown in the gallbladder. By removing these stones from these organs through a series of liver flushes and maintaining a balanced diet and lifestyle, the liver and gallbladder can restore their original efficiency, and most symptoms of discomfort or disease in the body can start subsiding. You may find that any persistent allergies will lessen or disappear. Back pain will dissipate, while energy and well-being will improve.

Sweeping the liver clean eliminates thousands of bits of poisonous substances that have helped form the stones and block thousands of liver bile ducts. Ridding the liver bile ducts from gallstones is one of the most important and powerful procedures you can apply to improve and regain your physical and emotional health. By reopening the bile ducts, the body's energy circuits become restored and healing can take place on all levels of body, mind and spirit.


Learn more:http://www.naturalnews.com/022271_liver_gallstones_gallbladder.html#ixzz1UTFUOetp

Coffee Benefits - Reduce Diabetes risk

Coffee Benefits | Control Stress: "And now there comes word of new medical research indicating that. When compared to those who don’t drink coffee, we dedicated coffee drinkers are probably less likely to have Parkinson’s disease, dementia, or type 2 diabetes. We are also statistically less likely to have certain cancers, problems with heart rhythms and strokes."

Thursday

Glucagonoma - Glucagonoma Causes, Risk Factors, Testing & Treatment

Glucagonoma - Glucagonoma Causes, Risk Factors, Testing & Treatment: "Glucagonoma is extremely rare, and occurs when a tumour forms in the islet cells of the pancreas, releasing insulin and glucagon.

This type of tumour is usually cancerous, and also usually spreads and becomes more serious over time. Glucagonoma influences the pancreatic islet cells, causing them to produce too much glucagon.

How is glucagonoma caused?

The causes of glucagonoma are currently unknown. In most cases it is suspected that genetic factors play a strong role. Having family members with multiple endocrine neoplasia type 1 (MEN1) is also regarded as being a risk factor."

Sunday

foodconsumer.org - Alzheimer's disease linked to depression, diabetes and high blood pressure

foodconsumer.org - Alzheimer's disease linked to depression, diabetes and high blood pressure: "health observer suggested so-called risk factors like depression, high blood pressure, diabetes and obesity are actually symptoms. What really causes risk of Alzheimer's disease would be what is causing these symptoms or health conditions. "

FDA Data Mining Uncovers Harmful Drug Interaction -- InformationWeekFDA Data Mining Uncovers Harmful Drug Interaction - healthcare Blog

FDA Data Mining Uncovers Harmful Drug Interaction -- InformationWeekFDA Data Mining Uncovers Harmful Drug Interaction - healthcare Blog: "Tatonetti, a PhD candidate in 2012, was lead author of a study that appeared in May in the online version of the journal Clinical Pharmacology and Therapeutics that found an interaction between the antidepressant paroxetine (Paxil) and the cholesterol-lowering drug pravastatin (Pravachol) that could put patients at risk of developing diabetes. Taking the two drugs together, Tatonetti and fellow researchers from Stanford, Vanderbilt University, and Harvard University reported, could cause blood glucose levels to spike."

Surgeons pioneer new ways to treat di... JPost - Health & Science

Surgeons pioneer new ways to treat di... JPost - Health & Science: "NewYork-Presbyterian/Columbia is using techniques from weight-loss surgery to improve blood glucose levels and correct a major complication of the disease."

Saturday

writings on the Islets of Langerhans

Writings on the Islets of Langerhans want to read my next novel? I am unveiling the draft plannings in my writing block. Pop along and have a read. It is raw, the grammer is awful, the spellings could be wrong, but the plot is developing day by day. Would love feedback !

Thursday

BBC News - Type 2 diabetes in newly diagnosed 'can be reversed'

BBC News - Type 2 diabetes in newly diagnosed 'can be reversed'

Bristol Diabetes Pill Faces Safety Hurdle After Early Drugs Tied to Risks

 EAV_BLOG_VER:79843941c6db5c8a

Bristol Diabetes Pill Faces Safety Hurdle After Early Drugs Tied to Risks



Bristol-Myers Squibb Co. (BMY) and AstraZeneca Plc. (AZN)’s new diabetes pill will probably face increased scrutiny from regulators and doctors after two rivals were tied to cancer and heart risks.
The drug, dapagliflozin, works differently than Takeda Pharmaceutical Co.’s Actos, linked to cancer last week, and GlaxoSmithKline Plc (GSK)’s Avandia, tied to heart risks in 2007. While those drugs adjust the hormone that regulates sugar, the new pill helps patients excrete sugar through their urine.
“Increasingly, people are on the lookout for problems with these drugs,” said Laurence Kennedy, chairman of Cleveland Clinic’s department of endocrinology, diabetes and metabolism, in a telephone interview. “There will always be a market for finding newer and different ways to help control blood sugar, but the newest ways will be under increasing scrutiny.”
Some analysts say they won’t project sales for dapagliflozin because of the risks posed by Avandia and Actos. Even if approved after a regulatory panel next month, doctors say they will be slow in using the new drug until more is known about long-term safety. A one-year study reported last year found no cancer or heart risks. Two years of data will be reported June 26 at the American Diabetes Association meeting.
An estimated 25.8 million Americans have diabetes, mostly the Type 2 variety linked to being overweight and sedentary, according to the National Institutes of Health. The disease is caused by an inability to use insulin to break down blood sugar into energy and can increase the risk of heart disease, stroke and kidney damage. Medicines are used to lower sugar levels.

Patients Lost Weight

The new drug is being developed jointly by New York-based Bristol-Myers and London-based AstraZeneca. The earlier trial showed it worked better than insulin plus a placebo, and that patients using it lost weight. This is particularly noteworthy because insulin drugs frequently trigger weight gain.
If approved, dapagliflozin would be the first in a new class of medications, called SGLT2-inhibitors. Similar drugs are also being developed by Johnson & Johnson, of New Brunswick,New Jersey, Indianapolis-based Eli Lilly & Co. (LLY) and the German drugmaker Boehringer Ingelheim GmbH, Tokyo-based Astellas Pharma Inc., Isis Pharmaceuticals Inc., based in Carlsbad, California, and Lexicon Pharmaceuticals Inc., of The Woodlands, Texas.
The companies, analysts and investors will be closely watching the safety results and a panel of Food and Drug Administration advisers that is set to review dapagliflozin on July 19, said Les Funtleyder, a portfolio manager at Miller Tabak in New York, in a telephone interview.

No Modeling

Concerns about potential side effects of all diabetes medications leave analysts little room to assess the sales potential of dapagliflozin, he said.
“With these type of drugs, we don’t model until they’re approved because so much can go wrong,” Funtleyder said. “We know it’s a new class in diabetes, which is often not well- controlled. The downside is people are nervous about possible infections and other side effects, and you have to take the good with the bad.”
Bristol-Myers referred comment to AstraZeneca. AstraZeneca’s spokeswoman Kirsten Evraire declined to comment.
In May, U.S. regulators restricted use of London-based Glaxo’s Avandia, ordering the drug to be pulled from pharmacy shelves and made available only through a special program. Sales of Avandia fell to $680 million last year from $1.8 billion in 2007 after a study that year showed a 43 percent increased risk of heart attacks among patients taking the medicine.
On June 15, a five-year analysis from a decade-long company-sponsored study of Takeda’s Actos showed an increased risk of bladder cancer. Actos is the world’s biggest-selling diabetes drug. The FDA had required the study under new guidelines for diabetes drug approvals.
$1.6 billion by 2017
Bristol-Myers’s and AstraZeneca’s Onglyza and Kombiglyze, a version of the drug combined with metformin, a standard treatment, generated $158 million last year. Those two drugs are projected to make $1.6 billion by 2017, according to estimates from Seamus Fernandez, an analyst for Leerink Swann.
Even after approval, “we still have an obligation to conduct studies carefully and properly just to make sure nothing major has been missed” said Kennedy, of the Cleveland Clinic.
Since its original warning on Avandia, the FDA has required an aftermarket study of heart risks for all diabetes drug applications, said Karen Riley, a spokeswoman for the FDA, in an e-mail.

‘New Lessons’

“Not all programs are identical and development isn’t static so as these data come in, we have to apply new lessons learned to the interpretation of risk assessment for subsequent programs,” she wrote.
The number of Americans with diabetes is expected to rise to as many as 1 in 3 adults if trends continue, according to the Atlanta-based Centers for Disease Control and Prevention.
This explosion in cases has spurred the development of at least nine classes of diabetes drugs, some oral and some injectable. Today there are more than 39 diabetes drugs on market, generating about $16.8 billion in U.S. sales in 2010, according to data from research firm IMS Health.
Only half of diabetes patients have their blood sugar under control, so there’s a need for new medications, said Martin Abrahamson, the chief medical officer of Joslin Diabetes Center, an affiliate of Harvard Medical School in Boston.
“Type 2 diabetes being a progressive disease, one drug, a single drug, is unlikely to be a control for glucose levels over many years,” Abrahamson said in a telephone interview. “Usually you add more medications to achieve glucose targets.”

First-Line Therapy

Metformin, approved for use in the U.S. in 1995, is almost universally accepted as a first-line therapy for diabetes, because it has a long safety record and is cheap, Abrahamson said. Often, though, it’s not enough.
Many people with Type 2 diabetes are overweight or obese, and have co-existing conditions such as heart disease and high blood pressure, Abrahamson said. Complications associated with the disease also make prescribing tricky, he said.
Given the difficulty in controlling the disease, doctors remain eager for new medications, even though they are “becoming more gun shy” as dangerous risks are uncovered after the drugs are approved, said Robert Rushakoff, medical director for inpatient diabetes at the University of CaliforniaSan Francisco.
“Given the reality of diabetes and how difficult it is, endocrinologists will be using it right away,” he said in an interview. “I know I’ll be using it right away. It’s easier than teaching someone to inject a medication. It’s a matter of once the drug moves out of studies, how those side-effects appear. More common, more severe or not a big deal?”

Diabetes Association Meeting

The data presented at the American Diabetes Association meeting in San Diego is expected to provide new details on dapagliflozin’s safety profile, said Tony Butler, an analyst with Barclays Capital in New York. He, like Miller Tabak’s Funtleyder, is unwilling to project sales at this point.
In the one-year study, dapagliflozin was linked to an increased likelihood of urinary tract and genital infections. While that’s a lesser concern than heart or cancer, it has raised red flags.
Rita Rastogi Kalyani an assistant professor of medicine at Johns Hopkins University in Baltimore, said the infections probably occur because the urinary tract is a more hospitable environment for bacteria when patients excrete more sugar in their urine.
“I think as much as we’re excited about new classes of medications, we’re still looking at the older medications first because they’ve been tested over time,” Kalyani said, referring to metformin. “We’ve seen an explosion of classes but we still don’t know about long-term risks.”